Technical Analysis for ACET - Adicet Bio, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 5.89 | 1.73% | 0.10 |
ACET closed up 1.73 percent on Friday, March 24, 2023, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New Downtrend | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 1.73% | |
Lower Bollinger Band Walk | Weakness | 1.73% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Possible NR7 | about 10 hours ago |
Possible Inside Day | about 10 hours ago |
Up 2% | about 12 hours ago |
60 Minute Opening Range Breakout | about 13 hours ago |
Up 1% | about 13 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/13/2023
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell Therapies For Cancer Chimeric Antigen Receptor T Cell Immune Response Adoptive Cell Transfer Antigen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell Therapies For Cancer Chimeric Antigen Receptor T Cell Immune Response Adoptive Cell Transfer Antigen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.87 |
52 Week Low | 5.64 |
Average Volume | 536,126 |
200-Day Moving Average | 13.28 |
50-Day Moving Average | 8.01 |
20-Day Moving Average | 7.28 |
10-Day Moving Average | 6.92 |
Average True Range | 0.54 |
RSI | 30.56 |
ADX | 25.72 |
+DI | 11.32 |
-DI | 34.45 |
Chandelier Exit (Long, 3 ATRs) | 6.59 |
Chandelier Exit (Short, 3 ATRs) | 7.27 |
Upper Bollinger Bands | 8.68 |
Lower Bollinger Band | 5.87 |
Percent B (%b) | 0.01 |
BandWidth | 38.67 |
MACD Line | -0.57 |
MACD Signal Line | -0.42 |
MACD Histogram | -0.1535 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.28 | ||||
Resistance 3 (R3) | 6.26 | 6.11 | 6.22 | ||
Resistance 2 (R2) | 6.11 | 6.01 | 6.12 | 6.19 | |
Resistance 1 (R1) | 6.00 | 5.95 | 6.06 | 6.02 | 6.17 |
Pivot Point | 5.85 | 5.85 | 5.88 | 5.86 | 5.85 |
Support 1 (S1) | 5.74 | 5.75 | 5.80 | 5.76 | 5.61 |
Support 2 (S2) | 5.59 | 5.69 | 5.60 | 5.59 | |
Support 3 (S3) | 5.48 | 5.59 | 5.57 | ||
Support 4 (S4) | 5.50 |